BLACK DIAMOND THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.89 USD | +15.26% |
|
+11.98% | +109.61% |
Chart calendar Black Diamond Therapeutics, Inc.
3dc78fecc64.CoZge7LLdhbRaJRkAThcQJDVP1lTL0Mi9YLWGvPEv98.fsgrDMOKRiC_EfotQ0AOMeCDfQskAhETh--fSYqb6-dL6QcW9Y09Y5clwQ~dd7398e25f6713e6a65fb8df2979a310
Upcoming events on Black Diamond Therapeutics, Inc.
Past events on Black Diamond Therapeutics, Inc.
| 16/04/2024 | Piper Sandler Spring Biopharma Symposium |
| 16/04/2024 15:00 | Stifel Virtual Targeted Oncology Days Conference |
| 10/04/2024 13:00 | Needham Healthcare Conference |
| 07/04/2024 23:00 | American Association for Cancer Research Meeting - Abstract No - 1229 |
| 12/03/2024 12:00 | Q4 2023 Earnings Release |
| 06/03/2024 14:10 | TD Cowen Health Care Conference - Panel |
| 29/11/2023 21:30 | Piper Sandler Healthcare Conference |
| 14/11/2023 19:25 | Stifel Healthcare Conference |
| 06/11/2023 12:45 | Q3 2023 Earnings Release |
| 14/10/2023 17:30 | AACR-NCI-EORTC International Conference - A Phase 1 Study to Assess BDTX |
| 14/10/2023 17:30 | AACR-NCI-EORTC International Conference - Phase 1 Study of BDTX |
| 12/10/2023 17:30 | AACR-NCI-EORTC International Conference - Preclinical Efficacy of BDTX |
| 12/09/2023 16:00 | H.C. Wainwright Global Investment Conference |
| 11/09/2023 20:35 | Morgan Stanley Global Healthcare Conference |
| 05/09/2023 | Wells Fargo Healthcare Conference |
| 11/08/2023 12:30 | Q2 2023 Earnings Release |
| 27/06/2023 13:00 | BDTX-1535 Phase 1 Clinical Study Results Call |
| 09/06/2023 17:45 | Jefferies Global Healthcare Conference |
| 16/05/2023 14:00 | Annual General Meeting |
| 08/05/2023 | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -29,3 -27,0 -8.46% | -69,5 -71,5 2.77% | -127 -137 7.54% | -92,3 -93,0 0.73% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -29,3 -27,2 -7.97% | -69,6 -69,1 -0.69% | -127 -138 7.8% | -92,8 -94,0 1.21% | -86,5 -90,2 4.18% | -95,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -35,3 -34,1 -3.27% | -67,3 -66,9 -0.54% | -126 -136 7.74% | -91,2 -92,6 1.59% | -82,4 -86,7 4.9% | -94,1 |
|
Net income Million USD | Released Forecast Spread | -35,3 -34,1 -3.27% | -67,3 -67,0 -0.44% | -126 -136 7.87% | -91,2 -93,0 1.95% | -82,4 -87,2 5.4% | -93,8 |
|
EPS USD | Released Forecast Spread | -17,0 -12,4 -36.69% | -2,05 -2,04 -0.32% | -3,47 -3,76 7.79% | -2,52 -2,56 1.37% | -1,88 -1,98 5.24% | -1,71 |
| Announcement Date | 24/03/20 | 25/03/21 | 17/03/22 | 09/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -26,0 -36,0 27.9% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -26,1 -36,8 29.19% | -25,7 -27,6 6.83% | -23,2 -24,9 6.96% | -22,1 -23,3 5.14% | -21,9 -23,0 4.81% | -21,6 -22,3 3.48% | -20,0 -22,3 10.08% | -24,0 -22,3 -7.47% | -20,9 -24,6 15.33% | -22,9 | -23,6 | -24,2 | -25,0 | -33,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,9 -36,6 29.31% | -25,5 -27,5 7.25% | -22,9 -24,4 6.04% | -21,7 -23,0 6.01% | -21,1 -22,4 5.79% | -20,9 -21,7 3.8% | -19,2 -21,8 12.19% | -23,0 -22,2 -3.6% | -19,4 -23,7 17.98% | -22,6 | -23,2 | -23,8 | -24,5 | -33,0 |
|
Net income Million USD | Released Forecast Spread | -25,9 -36,8 29.76% | -25,5 -27,4 6.97% | -22,9 -25,3 9.38% | -21,7 -23,2 6.79% | -21,1 -22,9 8.02% | -20,9 -22,0 4.99% | -19,2 -22,0 12.98% | -23,0 -22,0 -4.55% | -19,4 -24,1 19.57% | -22,4 | -23,0 | -23,7 | -24,6 | -33,0 |
|
EPS USD | Released Forecast Spread | -0,71 -1,01 29.88% | -0,70 -0,75 6.89% | -0,63 -0,70 9.68% | -0,60 -0,64 6.25% | -0,59 -0,63 5.85% | -0,57 -0,61 6.17% | -0,52 -0,54 2.8% | -0,45 -0,49 7.53% | -0,34 -0,47 27.04% | -0,44 | -0,43 | -0,43 | -0,41 | -0,49 |
| Announcement Date | 17/03/22 | 11/05/22 | 09/08/22 | 08/11/22 | 09/03/23 | 09/05/23 | 11/08/23 | 06/11/23 | 12/03/24 | - | - | - | - | - |
More events
Past sector events for Black Diamond Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BDTX Stock
- Calendar Black Diamond Therapeutics, Inc.
